Actively Recruiting
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation to Create Gero Friendly Organizations
Led by Penn State University · Updated on 2026-02-20
1050
Participants Needed
2
Research Sites
21 weeks
Total Duration
On this page
Sponsors
P
Penn State University
Lead Sponsor
M
Mount Nittany Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a new approach to daily delirium screening in older adults hospitalized in six general medicine and surgery units across three hospitals in Pennsylvania and Massachusetts. The study aims to test how well nurses can implement the UB-CAM screening tool in routine care and to assess its impact on patient outcomes, complications like falls and pressure injuries, and medication use related to delirium management. This trial focuses on patients aged 70 and older, including those with Alzheimer's disease or related dementias, and involves both patient and care partner participation. The UB-CAM delirium screening tool is integrated into the electronic health record and used by nurses daily during hospital stays. The study uses a stepped-wedge design, introducing UB-CAM screening to one hospital unit every six months over 42 months. Two groups are studied: a patient-oriented group where individuals provide consent and undergo detailed delirium assessments up to three times during their hospital stay, and an administrative group including all older patients admitted to the units, whose data will be analyzed from hospital records. Care partners also participate through interviews and follow-up calls. Participants are assessed for delirium daily during their hospital stay, up to three days or until discharge. They provide demographic information and are contacted one month after discharge to report on their health and care experiences. Care partners complete assessments at discharge and follow-up interviews one month later regarding communication and caregiving burdens. Researchers will measure the accuracy of nurse screenings, patient and caregiver outcomes, and rates of delirium-related complications and management practices. The study continues until 2028, with ongoing monitoring and data collection throughout hospital stays and follow-up periods.
CONDITIONS
Brief Title
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted to general medicine (hospitalist) service
- Age 70 years or older
- Expected hospital length of stay of 3 or more days
You will not qualify if you...
- Inability to communicate adequately in English
- Admitted for terminal care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - From hospital admission through discharge, an average of 1 week
Participants who undergo routine care are observed with daily delirium screening integrated into their electronic health record during their hospital stay.
Daily delirium screening during hospital stay
Duration - 1 month post-hospital discharge
Participants and their care partners are interviewed by telephone to assess outcomes such as Healthy Days at Home and distress one month after hospital discharge.
1 telephone interview
Trial Site Locations
Total: 2 locations
1
Beth Israel Deaconness Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
2
Mount Nittany Medical Center
State College, Pennsylvania, United States, 16801
Actively Recruiting
Research Team
D
Donna M Fick, PhD
K
Kerry A Palihnich, BA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here